JP4728615B2 - 免疫賦活能を有する酵母およびそれを含む食品 - Google Patents
免疫賦活能を有する酵母およびそれを含む食品 Download PDFInfo
- Publication number
- JP4728615B2 JP4728615B2 JP2004260771A JP2004260771A JP4728615B2 JP 4728615 B2 JP4728615 B2 JP 4728615B2 JP 2004260771 A JP2004260771 A JP 2004260771A JP 2004260771 A JP2004260771 A JP 2004260771A JP 4728615 B2 JP4728615 B2 JP 4728615B2
- Authority
- JP
- Japan
- Prior art keywords
- gene
- yeast
- atcc
- disrupted
- immunostimulatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims description 47
- 230000003308 immunostimulating effect Effects 0.000 title claims description 30
- 235000013305 food Nutrition 0.000 title claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 101150036170 gas-1 gene Proteins 0.000 claims description 14
- 101150077509 mcd-4 gene Proteins 0.000 claims description 12
- 210000002540 macrophage Anatomy 0.000 claims description 11
- 230000004913 activation Effects 0.000 claims description 10
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical group OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 8
- 101150054023 CWH41 gene Proteins 0.000 claims description 8
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 8
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 8
- 101150099211 BIG1 gene Proteins 0.000 claims description 5
- 230000003213 activating effect Effects 0.000 claims description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 11
- 244000005700 microbiome Species 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 101000577105 Homo sapiens Mannosyl-oligosaccharide glucosidase Proteins 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 210000005253 yeast cell Anatomy 0.000 description 5
- 102100036683 Growth arrest-specific protein 1 Human genes 0.000 description 4
- 101001072723 Homo sapiens Growth arrest-specific protein 1 Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 229920002498 Beta-glucan Polymers 0.000 description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 3
- 102100035189 GPI ethanolamine phosphate transferase 1 Human genes 0.000 description 3
- 101001093751 Homo sapiens GPI ethanolamine phosphate transferase 1 Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 208000026278 immune system disease Diseases 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 101710100912 Brefeldin A-inhibited guanine nucleotide-exchange protein 1 Proteins 0.000 description 2
- 102100025994 Brefeldin A-inhibited guanine nucleotide-exchange protein 1 Human genes 0.000 description 2
- 101150051438 CYP gene Proteins 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 102100025315 Mannosyl-oligosaccharide glucosidase Human genes 0.000 description 2
- 101000648740 Mus musculus Tumor necrosis factor Proteins 0.000 description 2
- 101150069538 ROT1 gene Proteins 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000002198 Annona diversifolia Nutrition 0.000 description 1
- 241000272517 Anseriformes Species 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 102100030981 Beta-alanine-activating enzyme Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000252185 Cobitidae Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101000773364 Homo sapiens Beta-alanine-activating enzyme Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 241000282838 Lama Species 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000277269 Oncorhynchus masou Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 241001282110 Pagrus major Species 0.000 description 1
- 241000269979 Paralichthys olivaceus Species 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000269908 Platichthys flesus Species 0.000 description 1
- 241000861915 Plecoglossus Species 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000223252 Rhodotorula Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 241000271567 Struthioniformes Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000894431 Turbinidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 241001233037 catfish Species 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 108010050669 glucosidase I Proteins 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019992 sake Nutrition 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 108010074488 uridine 5'-monophosphate synthase Proteins 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
(1) (a)MCD4遺伝子、GAS1遺伝子、及びBIG1遺伝子からなる群のうちのいずれか1つの遺伝子が破壊されている酵母、並びに、(b)前記GAS1遺伝子及びCWH41遺伝子の2つの遺伝子が破壊されている酵母、のいずれかの酵母を含有し、免疫賦活能を有することを特徴とする免疫賦活組成物である。
(2) 免疫賦活能がマクロファージ活性化能である前記(1)に記載の免疫賦活組成物である。
(3) (a)1つの遺伝子が破壊されている酵母が、MCD4遺伝子a型、MCD4遺伝子α型、及びGAS1遺伝子a型のいずれかの遺伝子が破壊されている酵母であり、
(b)2つの遺伝子が破壊されている酵母が、GAS1遺伝子及びCWH41遺伝子a型が破壊されている酵母、又はGAS1遺伝子及びCWH41遺伝子α型が破壊されている酵母である前記(1)から(2)のいずれかに記載の免疫賦活組成物である。
(4) MCD4遺伝子が破壊された酵母が、ATCC 4005015、ATCC 4015015、ATCC 4025015、及びATCC 4035015の少なくともいずれかであり、
GAS1遺伝子が破壊された酵母が、ATCC 4000897、ATCC 4010897、ATCC 4020897、及びATCC 4030897の少なくともいずれかであり、
CWH41遺伝子が破壊された酵母が、ATCC 4004395、ATCC 4014395、ATCC 4024395、及びATCC4034395の少なくともいずれかであり、
BIG1遺伝子が破壊された酵母が、ATCC 4011929、ATCC 4021929、及びATCC 4031929の少なくともいずれかである前記(1)から(3)のいずれかに記載の免疫賦活組成物である。
(5) マクロファージ活性化能が、TNF−α活性化能であり、
前記TNF−α活性化能が、野生型の酵母と比較して2倍以上である前記(2)から(4)のいずれかに記載の免疫賦活組成物である。
(6) 前記(1)から(5)のいずれかに記載の免疫賦活組成物を含有することを特徴とする食品である。
(http://www-sequence.stanford.edu/group/yeast_deletion_project/deletions3.html)などを通じ、ATCC(American Type Culture Collection)から一般に入手が可能である。
Claims (6)
- (a)MCD4遺伝子、GAS1遺伝子、及びBIG1遺伝子からなる群のうちのいずれか1つの遺伝子が破壊されている酵母、並びに、(b)前記GAS1遺伝子及びCWH41遺伝子の2つの遺伝子が破壊されている酵母、のいずれかの酵母を含有し、免疫賦活能を有することを特徴とする免疫賦活組成物。
- 免疫賦活能がマクロファージ活性化能である請求項1に記載の免疫賦活組成物。
- (a)1つの遺伝子が破壊されている酵母が、MCD4遺伝子a型、MCD4遺伝子α型、及びGAS1遺伝子a型のいずれかの遺伝子が破壊されている酵母であり、
(b)2つの遺伝子が破壊されている酵母が、GAS1遺伝子及びCWH41遺伝子a型が破壊されている酵母、又はGAS1遺伝子及びCWH41遺伝子α型が破壊されている酵母である請求項1から2のいずれかに記載の免疫賦活組成物。 - MCD4遺伝子が破壊された酵母が、ATCC 4025015であり、
GAS1遺伝子が破壊された酵母が、ATCC 4000897、ATCC 4010897、ATCC 4020897、及びATCC 4030897の少なくともいずれかであり、
CWH41遺伝子が破壊された酵母が、ATCC 4004395、ATCC 4014395、ATCC 4024395、及びATCC4034395の少なくともいずれかであり、
BIG1遺伝子が破壊された酵母が、ATCC 4021929である請求項1から3のいずれかに記載の免疫賦活組成物。 - マクロファージ活性化能が、TNF−α活性化能であり、
前記TNF−α活性化能が、野生型の酵母と比較して2倍以上である請求項2から4のいずれかに記載の免疫賦活組成物。 - 請求項1から5のいずれかに記載の免疫賦活組成物を含有することを特徴とする食品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004260771A JP4728615B2 (ja) | 2004-09-08 | 2004-09-08 | 免疫賦活能を有する酵母およびそれを含む食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004260771A JP4728615B2 (ja) | 2004-09-08 | 2004-09-08 | 免疫賦活能を有する酵母およびそれを含む食品 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006075039A JP2006075039A (ja) | 2006-03-23 |
JP4728615B2 true JP4728615B2 (ja) | 2011-07-20 |
Family
ID=36155014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004260771A Active JP4728615B2 (ja) | 2004-09-08 | 2004-09-08 | 免疫賦活能を有する酵母およびそれを含む食品 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4728615B2 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2228437A4 (en) | 2007-12-10 | 2011-03-23 | Oriental Yeast Co Ltd | YEAST WITH IMMUNE POTENZING EFFECT AND LIVING OR FEEDING AGENT |
JP5608344B2 (ja) * | 2009-06-09 | 2014-10-15 | オリエンタル酵母工業株式会社 | 免疫賦活能を有する酵母、及び、食品又は飼料 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07184595A (ja) * | 1993-12-28 | 1995-07-25 | Nippon Paper Ind Co Ltd | 酵母エキス組成物及びその製造法並びにそれを含有する飼料 |
-
2004
- 2004-09-08 JP JP2004260771A patent/JP4728615B2/ja active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07184595A (ja) * | 1993-12-28 | 1995-07-25 | Nippon Paper Ind Co Ltd | 酵母エキス組成物及びその製造法並びにそれを含有する飼料 |
Also Published As
Publication number | Publication date |
---|---|
JP2006075039A (ja) | 2006-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5315255B2 (ja) | 免疫賦活能を有する酵母、及び、食品又は飼料 | |
Ahmad et al. | A review on mycoprotein: History, nutritional composition, production methods, and health benefits | |
CN102906270A (zh) | 在木糖上生长的重组破囊壶菌和其组合物、制备方法及用途 | |
Shahid et al. | Microalgal carbohydrates and proteins: Synthesis, extraction, applications, and challenges | |
CN110087478A (zh) | 从生物质材料去除核酸及其片段 | |
NO342626B1 (en) | A new method to improve enzyme hydrolysis and resultant protein flavor and bio-activity of fish offcuts | |
JP4069253B2 (ja) | 栄養添加物の製造方法、添加物、およびその使用 | |
Chávez-Calvillo et al. | Differential gene expression in Litopenaeus vannamei shrimp in response to diet changes | |
CN108779483A (zh) | 使用烟曲霉三肽基肽酶生产蛋白水解产物的方法 | |
JP4313615B2 (ja) | 免疫賦活活性及びγ−アミノ酪酸産生能を有する新規乳酸菌、及びその利用。 | |
JP4728615B2 (ja) | 免疫賦活能を有する酵母およびそれを含む食品 | |
WO2012040980A1 (zh) | 一种海洋来源BacillusubarbaricusSCSIO02429以及用它制备鱿鱼小肽的方法 | |
JP5608344B2 (ja) | 免疫賦活能を有する酵母、及び、食品又は飼料 | |
JP6675967B2 (ja) | 飼料及びその製造方法 | |
JP2013053083A (ja) | 酵母タンパクの製法 | |
Das et al. | Genotyping of Clostridium perfringens from fresh water fish and fish pickles | |
JP2002027922A (ja) | 免疫賦活剤および飼料 | |
Binur et al. | Nutritional profiling of microfungi and its effects on the growth performance, bacterial communities, and survival with Vibrio harveyi on white shrimp post-larvae (Litopenaeus vannamei) | |
JP2020058321A (ja) | 藻類改変体を含む飲食品、飼料、又は餌料 | |
WO2021230252A1 (ja) | 魚介類の免疫を賦活させる組成物及びその方法 | |
CN116784421B (zh) | 一种唾液乳杆菌在牛蛙蝌蚪养殖中的应用 | |
KR102050019B1 (ko) | 면역증강용 사료첨가제, 이를 포함하는 배합사료 | |
JP4047354B2 (ja) | ドコサヘキサエン酸(dha)の生産性の高い新規ラビリンチュラ類微生物およびその利用 | |
JPH06263649A (ja) | 免疫賦活剤 | |
JP4047354B6 (ja) | ドコサヘキサエン酸(dha)の生産性の高い新規ラビリンチュラ類微生物およびその利用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070824 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20070927 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20071221 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100629 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100830 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110127 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110222 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110304 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110329 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110415 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4728615 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140422 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |